| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 144, 1045-1057, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
MJ Arends, AH McGregor and AH Wyllie
Department of Pathology, University Medical School, Edinburgh, United Kingdom.
Immortalized rat fibroblasts were transfected with expression plasmids containing a mutated human Ha-ras (T24) oncogene, human c-myc, HPV 16 or 18 genomes, or combinations of these. Cell proliferation rates in vitro of the resulting 13 transformed lines were closely similar but apoptotic rates in vitro varied over a 60-fold range and correlated inversely with rates of population expansion in culture. To determine whether such differences in susceptibility to apoptosis affected the pattern of tumor growth in vivo, the transfected lines were injected subcutaneously into immunesuppressed mice producing fibrosarcomas in which prevalence of apoptosis and mitosis, extent of necrosis, and net growth rate were measured. Cell lines with high apoptotic rates in vitro tended to generate slowly growing tumors with high ratios of apoptosis to mitosis and little necrosis. The three most extreme examples of this phenotype all resulted from single transfections with c-myc. Lines with low apoptotic rates in vitro generated rapidly expanding tumors with high mitotic rates, extensive necrosis, and little apoptosis relative to mitosis, even in the compromised zone at the edge of necrotic regions. The four fastest-growing tumors all contained a T24-ras oncogene. The results suggest that oncogene expression determines intrinsic apoptotic rates and in this way may significantly influence the net growth rate and extent of necrosis in tumors.
This article has been cited by other articles:
![]() |
D. M. Gascoyne, R. M. Kypta, and M. d. M. Vivanco Glucocorticoids Inhibit Apoptosis during Fibrosarcoma Development by Transcriptionally Activating Bcl-xL J. Biol. Chem., May 9, 2003; 278(20): 18022 - 18029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jackson, C. Harwood, M. Thomas, L. Banks, and A. Storey Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins Genes & Dev., December 1, 2000; 14(23): 3065 - 3073. [Abstract] [Full Text] |
||||
![]() |
A. Gandhi, P. A. Holland, W. F. Knox, C. S. Potten, and N. J. Bundred Effects of a Pure Antiestrogen on Apoptosis and Proliferation within Human Breast Ductal Carcinoma in Situ Cancer Res., August 1, 2000; 60(15): 4284 - 4288. [Abstract] [Full Text] |
||||
![]() |
J. Kamenz, W. Seibold, M. Wohlfrom, S. Hanke, N. Heise, C. Lenz, and H. Hanke Incidence of intimal proliferation and apoptosis following balloon angioplasty in an atherosclerotic rabbit model Cardiovasc Res, February 1, 2000; 45(3): 766 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tanaka, Y. Kawano, M. Li, T. Takata, R. Miyahara, K. Yanagihara, Y. Ohtake, T. Fukuse, and H. Wada Prognostic Significance of Apoptotic Index in Completely Resected Non-Small-Cell Lung Cancer J. Clin. Oncol., September 1, 1999; 17(9): 2728 - 2728. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Stehbens, S. Kondo, and N. Hashimoto Apoptosis and Matrix Vesicles in the Genesis of Arterial Aneurysms of Cerebral Arteries • Response Stroke, July 1, 1998; 29(7): 1478 - 1480. [Full Text] |
||||
![]() |
S. Kondo, N. Hashimoto, H. Kikuchi, F. Hazama, I. Nagata, H. Kataoka, and W. I. Rosenblum Apoptosis of Medial Smooth Muscle Cells in the Development of Saccular Cerebral Aneurysms in Rats • Editorial Comment Stroke, January 1, 1998; 29(1): 181 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Waksman, J. C. Rodriguez, K. A. Robinson, G. D. Cipolla, I. R. Crocker, N. A. Scott, S. B. King III, and J. N. Wilcox Effect of Intravascular Irradiation on Cell Proliferation, Apoptosis, and Vascular Remodeling After Balloon Overstretch Injury of Porcine Coronary Arteries Circulation, September 16, 1997; 96(6): 1944 - 1952. [Abstract] [Full Text] |
||||
![]() |
J. M. Isner, M. Kearney, S. Bortman, and J. Passeri Apoptosis in Human Atherosclerosis and Restenosis Circulation, June 1, 1995; 91(11): 2703 - 2711. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |